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ABSTRACT Human immunodeficiency virus type 1 (HIV-1) Nef enhances virus replication and contributes to immune evasion
in vivo, but the underlying molecular mechanisms remain incompletely defined. Nef interferes with host cell actin dynamics to
restrict T lymphocyte responses to chemokine stimulation and T cell receptor engagement. This relies on the assembly of a labile
multiprotein complex including the host kinase PAK2 that Nef usurps to phosphorylate and inactivate the actin-severing factor
cofilin. Components of the exocyst complex (EXOC), an octameric protein complex involved in vesicular transport and actin
remodeling, were recently reported to interact with Nef via the samemolecular surface that mediates PAK2 association. Explor-
ing the functional relevance of EXOC in Nef-PAK2 complex assembly/function, we found Nef-EXOC interactions to be specifi-
cally mediated by the PAK2 interface of Nef, to occur in infected human T lymphocytes, and to be conserved among lentiviral
Nef proteins. In turn, EXOCwas dispensable for direct downstream effector functions of Nef-associated PAK2. Surprisingly,
PAK2 was essential for Nef-EXOC association, which required a functional Rac1/Cdc42 binding site but not the catalytic activity
of PAK2. EXOCwas dispensable for Nef functions in vesicular transport but critical for inhibition of actin remodeling and prox-
imal signaling upon T cell receptor engagement. Thus, Nef exploits PAK2 in a stepwise mechanism in which its kinase activity
cooperates with an adaptor function for EXOC to inhibit host cell actin dynamics.
IMPORTANCE Human immunodeficiency virus type 1 (HIV-1) Nef contributes to AIDS pathogenesis, but the underlying molec-
ular mechanisms remain incompletely understood. An important aspect of Nef function is to facilitate virus replication by dis-
rupting T lymphocyte actin dynamics in response to stimulation via its association with the host cell kinase PAK2.We report
here that the molecular surface of Nef for PAK2 association also mediates interaction of Nef with EXOC and establish that PAK2
provides an essential adaptor function for the subsequent formation of Nef-EXOC complexes. PAK2 and EXOC specifically co-
operate in the inhibition of actin dynamics and proximal signaling induced by T cell receptor engagement by Nef. These results
establish EXOC as a functionally relevant Nef interaction partner, emphasize the suitability of the PAK2 interaction surface for
future therapeutic interference with Nef function, and show that such strategies need to target activity-independent PAK2 func-
tions.
Received 31 July 2015 Accepted 5 August 2015 Published 8 September 2015
Citation Imle A, Abraham L, Tsopoulidis N, Hoflack B, Saksela K, Fackler OT. 2015. Association with PAK2 enables functional interactions of lentiviral Nef proteins with the
exocyst complex. mBio 6(5):e01309-15. doi:10.1128/mBio.01309-15.
Invited Editor Thomas E. Smithgall, University of Pittsburgh School of Medicine Editor Vinayaka R. Prasad, Albert Einstein College of Medicine
Copyright © 2015 Imle et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-ShareAlike 3.0 Unported license,
which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
Address correspondence to Oliver T. Fackler, oliver.fackler@med.uni-heidelberg.de.
The efficacy with which human immunodeficiency virus type 1(HIV-1) replicates in the infected host is governed by a com-
plex set of parameters, including the intrinsic replication capacity
of the specific virus strain, the potency of the host immune system,
and the ability of the virus to evade immune recognition. The
so-called accessory genes (vif, vpu, vpr, and nef) play important
roles in optimizing HIV-1 spread in vivo while, depending on the
culture conditions used, they can be dispensable for virus replica-
tion ex vivo. The Nef protein exerts pronounced effects on in vivo
virus replication and pathogenicity, yet the relevant molecular
mechanisms of action remain little defined.
Nef is a myristoylated 25- to 34-kDa protein encoded by
HIV-1, HIV-2, and simian immunodeficiency virus (SIV). While
entirely dispensable for virus replication in cultured cells, Nef po-
tently increases virus replication and thus serves as a pathogenicity
factor that accelerates disease progression in the infected host (1–
3). This role of Nef in AIDS pathogenesis is also supported by a
transgenic-mouse model in which expression of Nef induces
AIDS-like depletion of CD4 T lymphocytes (4, 5). It is generally
assumed that Nef has no enzymatic activity but rathermediates its
functions through a large set of interactions with cellular proteins.
By virtue of this adaptor function, Nef affects many central pro-
cesses in HIV target cells. This includes modulation of cellular
transport pathways leading to the downregulation of an array of
receptors from the surface of infected cells, which, e.g., prevents
superinfection (6, 7) and lysis of productively infected cells by
cytotoxic T or NK cells (8–10). Nef also enhances HIV-1 particle
infectivity (11–14). Finally, HIV-1 Nef alters the response of CD4
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T lymphocytes to stimulation via the T cell receptor (TCR), and
modulation of the resulting cellular signaling pathways is thought
to increase virus replication in the infected host (15–20). One
mechanism by which Nef alters TCR signaling is retargeting of
active pools of the Src family kinase Lck from the plasma mem-
brane to recycling endosomes and the trans-Golgi network (TGN)
(16, 19, 21–25). This compartmentalization of T-cell receptor
(TCR) signaling modifies the response of infected T lymphocytes
to stimulation by blocking proximal TCR signaling at the plasma
membrane and simultaneously triggering a signaling cascade ini-
tiated at intracellular membranes (16, 19, 26, 27).
In addition to these alterations of host cell vesicular transport,
some of Nef’s activities are mediated by its ability to reduce host
cell actin remodeling (28–32). Such reduced actin remodeling re-
stricts the ability of T lymphocytes to undergo morphological
changes triggered by extracellular stimuli such as TCR engage-
ment and limits their motility toward chemoattractants (23, 29,
31, 33–35). While the physiological consequences of these effects
still remain to be elucidated, impaired T lymphocyte motility and
cell-cell communication in lymph nodes of infected individuals
may favor virus spread and limit the mounting of humoral im-
mune responses (36).
The identification of which molecular interactions of Nef con-
tribute to its role in HIV pathogenesis has been hampered by the
large number and low affinity of the ligands identified, aswell as by
the fact thatmultiple interaction partners were identified formost
of Nef’s protein interactionmotifs (37–39). Interference with host
cell actin remodeling has been an exception in this regard, as it
strictly depends on a hydrophobic patch not involved in any other
Nef activity reported to date (31, 40–42). Via this patch, Nef asso-
ciates with a highly active subpopulation of the host cell kinase
PAK2 (43, 44) andNef increases overall PAK2 activity in some cell
systems (45). In the case of a HIV-1 clade B Nef such as SF2 or
NL4.3, this binding pocket includes a critical phenylalanine (F195
in the case of Nef from HIV-1 SF2), mutations of which specifi-
cally disrupt PAK2 association. Association with Nef alters the
specificity of PAK2 and results in phosphorylation and thus inac-
tivation of the actin-severing factor cofilin to reduce actin remod-
eling and thus motility (31, 35, 46). These Nef effects on host cell
actin dynamics may also involve additional PAK2-dependent
mechanisms and substrates. Nef-PAK2 association occurs in
detergent-resistant membrane microdomains (47, 48) and within
a larger macromolecular complex (49). Nef-PAK2 complexes are
very unstable, and while Nef-associated PAK2 activity can readily
be demonstrated by in vitro kinase assay (IVKA), detection of
Nef-associated PAK2 protein by less sensitive methods such as
Western blotting is difficult (43, 44, 49). The full composition of
the Nef-PAK2 complex remains to be determined; however, the
PAK2-activating small GTPases Cdc42/Rac1, as well as their gua-
nine exchange factor Vav1, were identified as relevant complex
components (28, 50–52).
More recent work identified the exocyst complex (EXOC) as a
novel cellular ligand of the Nef proteins of HIV-1 NL4-3 (subtype
B) and 5C (subtype C) (53, 54). EXOC is an evolutionarily con-
served octameric complex thought to tether post-Golgi vesicles to
the plasma membrane during polarized secretion. In addition,
EXOC has been implicated in the regulation of cell motility by
mechanisms that are not linked to its role in exocytosis. Multiple
interactions with cytoskeletal players (such as the small GTPases
Cdc42 and Ral or the actin nucleator Arp2/3) position EXOC at
the interface between vesicle trafficking and polarized cytoskeletal
regulation (55–61).
On the basis of silencing experiments, Mukerji et al. suggested
EXOC as a mediator of Nef’s ability to promote the formation of
filopodium-like cell protrusions or nanotubes (53). However,
nanotube induction by Nef is a rare event (29, 35) and EXOC is a
core component critical for their formation (62). The functional
relevance of the Nef-EXOC interaction thus remains to be deter-
mined. Importantly, the interaction with EXOC required residues
also mediating Nef-PAK2 association (53). This finding chal-
lenged for the first time the specificity of these residues for Nef-
PAK2 association and suggested that (i) Nef may independently
associate with PAK2 and EXOC via these residues or (ii) associa-
tion of the viral protein with PAK2 and EXOC is coordinated. We
therefore set out to investigate the functional relevance of theNef-
EXOC interaction and its relationship to PAK2 association.
RESULTS
Interactions with EXOC via PAK2 association motifs occur in
HIV-infected T lymphocytes and are conserved among lentivi-
ralNef proteins. In a first set of experiments, we testedwhetherwe
could detect the association ofHIV-1Nef with EXOC as described
by Mukerji et al. (53). To this end, we transfected Jurkat T lym-
phocytes with expression plasmids for green fluorescent protein
(GFP), HIV-1 SF2 Nef fused with GFP (Nef.GFP), or Nef.GFP
mutant proteins and immunoisolated these proteins with GFP-
Trap beads (Fig. 1A). EXOC subunit 2 (EXOC2) was readily de-
tected inNef.GFP but notGFP immunoprecipitates. Consistently,
mass spectrometry identified all eight EXOC subunits as specifi-
cally enriched when liposomes that carried myristoylated Nef
were incubatedwith cell lysate and subsequently isolated bymem-
brane flotation to identify host cell interaction partners of
membrane-associated Nef (63; data not shown). Analyses to
probe for the presence ofNef.GFP in anti-EXOC immunoprecipi-
tations were hampered by the lack of antibodies that immunoiso-
late endogenous EXOC subunits without compromising EXOC
integrity and the instability of overexpressed epitope-tagged
EXOC subunits (data not shown; 64). Mukerji et al. reported that
the interaction of 5CNef, a hyperactive Nef variant with regard to
association with PAK2 activity (40), with EXOC required PAK2-
interacting residues (53). PAK2-interacting surfaces are, in prin-
ciple, conserved among lentiviralNef proteins, although their spe-
cific amino acid architecture varies and, as, e.g., in 5C Nef, often
does not contain a phenylalanine (see Fig. S1A in the supplemen-
tal material). In the case of SF2 Nef, the Nef-PAK2 association is
disrupted by the F195A mutation or mutation of the proline-rich
SH3 domain binding motif (mutant Nef protein AxxA) (38).
These mutations strongly reduced Nef’s association with EXOC2
(Fig. 1A to C, 23.2%  17.0% for F195A and 11.9%  9.5% for
AxxA, i.e., percentage of coimmunoprecipitated EXOC2 of im-
munoprecipitated GFP expressed relative to that of wild-type
[WT] SF2, which was set to 100%). More extensive screening of a
panel of well-characterized mutant Nef proteins (Fig. 1B and C)
revealed that a mutant Nef protein with a disruption of the acidic
stretch mediating interaction with the sorting adaptors PACS/
AP-1 (E4A4) (65–67) also displayed only residual interactionwith
EXOC inmost of our experiments (19.3% 12.5%; see Fig. S2 in
the supplemental material for a single experiment in which the
interaction was enhanced). This acidic stretch thus represents an
additional determinant in Nef for EXOC interaction that is also
Imle et al.
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required for Nef-PAK2 association (22, 67). Overall, the molecu-
lar determinants for association with EXOC and PAK2 seem to
overlap in both the 5C and SF2 Nef proteins. Disruption of the
myristoyl acceptor G2, which reduces the association of Nef with
cellular membranes (68), weakened Nef’s association with EXOC
(G2AmutantNef, 39.8% 34.9% [68], 82% in Fig. 1B; see Fig. S2
in the supplemental material for examples of experiments with
more strongly reduced coimmunoprecipitation of G2A mutant
FIG 1 Interactions of Nef with EXOC via the PAK2 association site occur in HIV-infected cells and are conserved among lentiviral Nef proteins. (A and B)
Mapping of HIV-1 Nef determinants for EXOC association. Jurkat T lymphocytes (Jurkat TAg) were transfected with constructs encoding GFP, SF2 Nef.GFP,
or Nef.GFP mutant proteins, and at 24 h posttransfection, cells were lysed and subjected to immunoprecipitation with GFP-Trap beads. Input and immuno-
precipitate (IP) samples were analyzed by SDS-PAGE and Western blotting. Note that, e.g., G2A mutant Nef in panel B is enriched in the immunoprecipitates
relative to the WT and thus displays reduced EXOC binding. (C) Quantification of relative coimmunoisolated EXOC2 as shown in panel B. Percentages of
coimmunoprecipitated EXOC2 and immunoprecipitated GFP were calculated relative to the percentage of SF2 WT Nef, which was set to 100%. Depicted are
means  standard deviations of up to seven independent experiments. (D) Coimmunoprecipitation of Nef and EXOC from HIV-1-infected cells. Jurkat T
(CCR7) cells were infected with WT HIV-1 or the isogenic HIV-1 strain expressing F195A mutant Nef and subjected to immunoprecipitation with a sheep
anti-Nef antibody. (E and F)Nef-EXOC association for differentHIV-1,HIV-2, and SIVNef alleles. Coimmunoprecipitation analysis (analogous to that in panel
A) of Jurkat TAg cells transiently expressing the indicated YFP or Nef.YFP protein with corresponding quantification (F) of three independent experiments with
means  standard deviations indicated. Nef and EXOC2 association is considered when at least 25% of SF2 WT Nef, which is indicated by dashed lines. The
values to the left of the blots are molecular sizes in kilodaltons.
Cooperation of PAK2 and EXOC in Nef Function
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Nef with EXOC2). Residues thatmediate the incorporation of Nef
into membrane microdomains (KKAA [68]) or association with
components of the endocytic machinery (LLAA, EDAA [69, 70])
were dispensable for this interaction.Disruption of the interaction
motif with the Nef-associated kinase complex (12-39) (71) re-
sulted in variable EXOC interaction efficiency (also see Fig. S2 in
the supplemental material).
Importantly, F195-dependent association of SF2 Nef with
EXOC2 was also observed when the viral protein was isolated
with a Nef-specific antibody from Jurkat T lymphocytes infected
with HIV-1 (Fig. 1D). The ability to associate with EXOC2 was a
conserved property of lentiviral Nef-yellow fluorescent protein
(YFP) from HIV-1 (SF2, NL4.3, 8161k9), HIV-2 (Ben), and SIV
(mac239, Cpz Gab2, Tan3), which were previously validated to
exert biological Nef activities (17, 25, 35). This conserved binding
demonstrated that while F195 is critical for this association of SF2
Nef, other Nef alleles contain binding interfaces that do not con-
tain such a critical phenylalanine residue (see Fig. S1A in the sup-
plemental material). The efficiency of the interaction varied be-
tween different Nef alleles but was above the residual binding
observed with SF2 Nef PAK2 binding-deficient mutant proteins
(relative Nef-EXOC2 associations ranging from 36.0%  36.4%
for NL4.3 to 190.0%  56.4% for 8161k9). Among the limited
number of alleles tested, the efficiency of the interaction with
EXOC correlated with (i) that of the association with PAK2 activ-
ity (see Fig. S1B andC) (35) and, similar to PAK2 association (72),
(ii) with an R-to-T polymorphism at the position upstream of the
second proline of Nef’s proline-richmotif (see Fig. S1A).We con-
clude that Nef-EXOC interactions in T lymphocytes require the
interaction surfaces mediating Nef association with PAK2 but not
others of its known protein interaction motifs, occur in the con-
text of HIV-1 infection, and are conserved in lentiviral evolution.
PAK2 is essential for the association of Nef with EXOC. Be-
cause of the striking overlap between the determinants involved in
Nef’s association with PAK2 and EXOC and the correlation of
binding efficiency among Nef alleles, we investigated whether the
presence of PAK2 has an impact on the ability of Nef to associate
with EXOC. To this end, we generated stable Jurkat cells express-
ing an unrelated control short hairpin RNA (shRNA; Jurkat
shCon) or an shRNA targeting PAK2 expression (Jurkat shPAK2)
(Fig. 2A). In Jurkat shCon cells, all of the EXOC subunits reported
to interact with Nef (EXOC1 to EXOC4) (53) were detected in
Nef.GFP immunoprecipitates. In sharp contrast, Nef-EXOC asso-
ciation was almost completely abrogated in Jurkat shPAK2 cells in
which PAK2 expression was undetectable by Western blotting.
These results indicate that PAK2 is essential for the association of
Nef with EXOC.
To gain insight into the molecular mechanism by which PAK2
facilitates the association of Nef with EXOC, we examined the
molecular determinants of PAK2 required for this effect. To this
end, we generated shPAK2-resistant expression constructs for
well-established mutant PAK2 proteins with defects in individual
functionally relevant amino acid motifs (48) (Fig. 2B) and tested
these proteins for the ability to reconstitute Nef-EXOC associa-
tion in Jurkat shPAK2 cells. As before (Fig. 2A), only residual
association of Nef.GFP with EXOC2 was observed in Jurkat
shPAK2 cells (Fig. 2C). Robust Nef-EXOC2 interaction was res-
cued upon the introduction of shRNA-resistantWTPAK2, as well
asmost of themutant PAK2proteins analyzed. Somewhat surpris-
ingly, reconstitution of Nef-EXOC association was also achieved
with catalytically inactive K278R mutant PAK2. Consistent with
the dispensability of PAK2 kinase activity for the assembly of Nef-
EXOC complexes, the PAK2 kinase inhibitor IPA3 reduced Nef-
associated PAK2 activity but did not affect Nef-EXOC association
(see Fig. S3 in the supplemental material). In contrast, the H82L/
H85L and ISP (I74N/S75P/P77A) mutant PAK2 proteins com-
pletely failed or were significantly impaired in reconstituting Nef-
EXOC interaction, respectively. These mutations disrupt the
interaction of PAK2 with the GTPases Rac1/Cdc42 and thereby
keep PAK2 in an autoinhibited, dimerized conformation (73). To
distinguish between the impact of GTPase-binding and autoin-
hibited conformations of PAK2 for facilitating the interaction of
Nef with EXOC, theH82L/H85L and L106Fmutations were com-
bined to result in a GTPase binding-deficient but conformation-
ally active PAK2 variant (73) (Fig. 2D). Since this mutant protein
failed to establish efficient association of Nef with EXOC, we con-
clude that Nef-associated PAK2 facilitates the assembly of Nef-
EXOC complexes via its ability to interact with small GTPases but
not via its kinase activity or conformational switching.
EXOC does not affect downstream functions of Nef-
associated PAK2. To test the influence of EXOC on Nef-PAK2
association, we attempted to generate shRNA lines lacking the
expression of individual EXOC subunits but failed to generate
viable cells with stably reduced EXOC expression levels (data not
shown). Transient small interfering RNA (siRNA)-mediated si-
lencing of EXOC4 and EXOC2 significantly reduced the expres-
sion but did not completely deplete these EXOC subunits, and
knockdown of one EXOC subunit frequently decreased the ex-
pression levels of other subunits (Fig. 3A, input; see Fig. S7A in the
supplementalmaterial). This reduction of EXOCexpression levels
markedly decreased the association of Nef with EXOC. Under
these conditions, Nef’s association with PAK2 activity, as scored
by autophosphorylation of PAK2 following immunoprecipitation
ofNef in an IVKA,was also reduced but still clearly detectable. The
Nef-PAK2 IVKA measures the stability of Nef-PAK2 complexes;
however, also shorter-lived Nef-PAK2 complexes can be fully
functional when assessing the phosphorylation of the PAK2 sub-
strate cofilin (35). To more precisely determine whether EXOC is
relevant for downstream functions of the Nef-PAK2 complex, we
therefore assessed the ability of Nef to induce high levels of inac-
tive p-cofilin in Jurkat T lymphocytes upon the silencing of PAK2,
EXOC2, or EXOC4 (Fig. 3B and C). Expectedly (31), p-cofilin
levels of GFP-expressing control cells were only rarely elevated
relative to those of untransfected neighboring cells (23.4% 
5.2% of cells with high p-cofilin levels, see also Fig. S4A in the
supplemental material for dual-color images), while cells express-
ing SF2 Nef.GFP frequently displayed high p-cofilin levels (80.8%
 5.2% of cells). Silencing of PAK2 expression largely eliminated
this Nef effect (40.6%  0.7% of cells with high p-cofilin). In
contrast, treatment with siEXOC2 or siEXOC4 had no effect on
the induction of p-cofilin by Nef.GFP (82.1% 6.6% and 83.0%
 0.9% of cells, respectively). Similar results were obtained when
analyzing the inhibitory effect of Nef on chemokine-mediated re-
modeling of the plasmamembrane and chemotaxis (Fig. 3D to F).
Stimulation of T cells with the chemoattractant stromal cell-
derived factor 1 (SDF-1) induces the formation of pronounced
F-actin-rich cell protrusions (actin ruffles). Actin ruffling is nec-
essary for directionalmigration toward a chemokine gradient, and
the formation of these protrusions is inhibited by Nef (29, 31)
(Fig. 3D). Whereas the majority of control GFP-positive cells dis-
Imle et al.
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FIG 2 The GTPase interaction site of PAK2 is essential to facilitate interactions of Nef with EXOC. (A) Nef-EXOC coimmunoprecipitation as in Fig. 1 from
Jurkat shCon and Jurkat shPAK cells transiently expressingGFP or SF2Nef.GFP. (B) Schematic illustration of the domain organization and functionally relevant
residues of PAK2. The ISP (I74N/S75P/P77A) and H82L/H85L mutant PAK2 proteins lack binding to Rac/Cdc42 because of disruption of the p21 binding
domain (PBD). The L106F and K278R mutations partially disrupt PAK2 autoinhibition or abolish PAK2 activity, respectively. AID, autoinhibitory domain. (C
and D) Reconstitution of Nef-EXOC coimmunoprecipitation in Jurkat shPAK2 cells by expression of shRNA-resistant PAK2 variants. Coimmunoprecipitation
as in panel A but upon transient coexpression of the indicated PAK2 variants. The values to the left of the blots are molecular sizes in kilodaltons.
Cooperation of PAK2 and EXOC in Nef Function
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FIG 3 EXOC does not affect Nef-PAK2 downstream functions. (A) Nef-associated PAK2 activity. Jurkat T (TAg) lymphocytes were transfected with siRNA
pools targeting EXOC2 or EXOC4 or the respective siRNA control and retransfected with a GFP or SF2Nef.GFP expression plasmid 48 h later. At 24 h after DNA
transfection, cells were lysed and subjected to GFP-Trap immunoprecipitation with subsequent IVKA. Samples were analyzed by SDS-PAGE and subjected to
autoradiography and Western blotting to reveal the association of Nef with PAK2 activity (resulting in autophosphorylation of the kinase) and EXOC,
respectively. The values to the left of the blots are molecular sizes in kilodaltons. (B and C) Induction of inactive p-cofilin by Nef. (B) Representative confocal
micrographs of Jurkat T (CCR7) lymphocytes transiently expressing GFP or Nef.GFP in the context of shRNA-mediated depletion of PAK2, siRNA-mediated
reduction of EXOC2 or EXOC4, or the respective control. Cells were plated onto coverslips, fixed, permeabilized, and stained for p-cofilin. Asterisks indicate
GFP-positive cells. Scale bar, 10 m. For dual-color images, see Fig. S4A in the supplemental material. (C) Frequency of the cells shown in panel B with high
p-cofilin levels. Depicted are mean values  standard deviations of three independent experiments with at least 100 cells counted per condition. (D and E)
(Continued)
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played such chemokine-induced ruffles (86.9%  2.5% of cells;
see also Fig. S4B in the supplemental material for dual-color im-
ages), expression of Nef.GFP potently reduced the fraction of ruf-
fling cells (4.9% 2.0% of cells).While silencing of PAK2 expres-
sion almost fully restored the formation of actin ruffles in
Nef.GFP-expressing Jurkat cells (72.2%  6.6%), silencing of
EXOC2 or EXOC4 had no effect (7.4% 3.7% and 5.3% 4.1%,
respectively) (Fig. 3E). Consistently, silencing of PAK2, but not of
EXOC, partially restored the chemotaxis of Nef.GFP-expressing
Jurkat T cells toward SDF-1 in a transwell migration assay
(63.2%  3.8% of shPAK2-treated cells versus 24.8%  5.7% of
siEXOC2-treated cells or 24.8%  6.0% siEXOC4-treated cells,
Fig. 3F). Together, these results suggest that EXOC stabilizes the
association of Nef with PAK2 but is not essential for the induction
of downstream functions of Nef-PAK2 complexes.
EXOC is dispensable for deregulation of trafficking of host
transmembrane and peripheral membrane proteins by Nef. To
investigate which biological activities of Nef involve EXOC, we
first addressed the downregulation of cell surface receptors. To
this end, we transiently expressed GFP or SF2Nef.GFP in Jurkat T
cells and determined relative cell surface protein levels as themean
receptor intensity of highly expressing cells as a percentage of that
of untransfected cells in the same sample. Values are expressed
relative to those in GFP-positive control cells, which were set to
100% (Fig. 4) (9). This allowed us to determine the effect of ecto-
pic viral gene expression on the relative steady-state surface expo-
sure of each receptor analyzed. In the case of CD4, Nef.GFP in-
duced a potent reduction of cell surface exposure to
approximately 30% of that of GFP-expressing control cells, de-
spite the heterogeneous levels of this receptor on the surfaces of
the cells used (Fig. 4A). Similar CD4 downregulation by Nef.GFP
was observed upon the reduction of PAK2, EXOC2, or EXOC4
expression (Fig. 4B). Downregulation of cell surface CXCR4
(Fig. 4C and D) and major histocompatibility complex class I
(MHC-I) (Fig. 4E and F), which is less pronounced than down-
regulation of CD4 and occurs via distinct molecular mechanisms
(7, 74), was also largely unaffected upon the silencing of PAK2 or
EXOC expression. Only for MHC-I downregulation did we ob-
serve a mild effect of PAK2 silencing (60.4%  6.6% of MHC-I
expression compared to 38.2%  5.7% in matched controls),
while silencing of EXOC had no effect. Finally, we assessed retar-
geting of the peripheral membrane protein Lck from the plasma
membrane to an intracellular compartment previously identified
as the TGN, which results from a Nef-mediated block of antero-
grade transport of newly synthesized and recycling Lck protein
(16, 24, 75). As expected, Lck prominently localized to the plasma
membrane with virtually no accumulation in intracellular com-
partments in GFP-expressing control Jurkat T lymphocytes (1.3%
 0.6% cells with Lck accumulation in the TGN) (Fig. 4G; see
Fig. S4C in the supplemental material for dual-color images) and
Nef.GFP triggered potent intracellular accumulation of the kinase
in a large majority of the cells (97.1%  3.0% of cells with Lck
accumulation in the TGN). This Nef-mediated retargeting of Lck
was fully preserved in cells with reduced expression of PAK2,
EXOC2, or EXOC4. We conclude that interactions of Nef with
PAK2 and EXOC are not involved in the Nef-mediated misrout-
ing of host cell receptors and peripheral membrane proteins.
EXOC is involved in the inhibition of TCR-induced actin re-
modeling by Nef. T cell activation is governed primarily by sig-
naling elicited by engagement of the TCR in a tight contact with
antigen-presenting cells referred to as the immunological synapse
(IS) (76). TCR engagement by specific MHC-presented peptides
launches highly dynamic and coordinated transport events that
recruit specific factors to the IS and exclude others from it. This
signal initiation triggers a broad cascade of downstream signaling
that includes dynamic F-actin remodeling at the IS, tyrosine phos-
phorylation, and release of calcium flux, which are coordinated to
trigger transcriptional profiles, including induced expression of
the T-cell survival cytokine interleukin-2 (77). Many aspects of
these events can be simulated when applying T lymphocytes to a
surface that triggers TCR signaling, e.g., by coating with anti-CD3
antibodies. T lymphocytes adhere to and rapidly spread on the
substratum under these conditions, and these processes are paral-
leled by marked remodeling of F-actin into pronounced circum-
ferential F-actin rings.WhileHIV-1Nef does not affect T lympho-
cyte adhesion on such stimulatory surfaces, cell spreading and
formation of circumferential F-actin rings are strongly inhibited
by the viral protein in an F195-dependent manner (22, 23, 26). As
expected, expression of Nef.GFP in Jurkat T lymphocytes treated
with control siRNA or shRNA resulted in small cells with little
peripheral F-actin, thus reducing the frequency of cells that
formed circumferential F-actin-rich rings (25.5%  4.2% and
34.3% 8.1% of cells, respectively) (Fig. 5A and B; see Fig. S5 in
the supplemental material for more examples and dual-color im-
ages). This Nef-mediated block of TCR-induced cell spreading
and actin polymerization was almost completely abolished in Ju-
rkat shPAK2 cells (78.5% 2.0% in Nef-expressing shPAK2 cells
versus approximately 92.8% 4.0% inGFP shCon). Importantly,
silencing of EXOC2 or EXOC4 also significantly increased the
frequency of Nef.GFP-expressing cells with circumferential
F-actin-rich rings (56.9%  11.6% and 67.1%  11.3%, respec-
tively). Four morphotypes could be distinguished under these ex-
perimental conditions (Fig. 5C, inset): fully spread cells with a
circumferential F-actin ring (black bars, prototypic of GFP-
expressing cells), incompletely spread cells with a circumferential
F-actin ring (dark gray bars), fully spread cells lacking circumfer-
ential F-actin polymerization (light gray bars), and cells that failed
to spread and lacked a circumferential F-actin ring (white bars,
Figure Legend Continued
Inhibition of chemokine-induced actin ruffling by Nef. (D) Representative maximum projections of confocal Z-stacks of GFP- or Nef.GFP-expressing Jurkat T
(CCR7) lymphocytes upon silencing of PAK2 or EXOC expression. Cells were used to seed coverslips at 24 h posttransfection with expression constructs,
stimulatedwith 200 ng/ml SDF-1 for 20min, fixed, permeabilized, and stainedwith phalloidin-TRITC to visualize F-actin. Asterisks indicateGFP-positive cells.
Scale bar, 10 m. For dual-color images, see Fig. S4B in the supplemental material. (E) Frequency of cells shown in panel D with chemokine-induced ruffles.
Depicted aremean values standard deviations of three independent experiments with at least 100 cells counted per condition. (F) Chemotaxis toward SDF-1.
Cells shown in panel D were starved and allowed to migrate through a 5-m porous transwell filter toward an SDF-1 gradient for 2 h. Migrated cells were
quantified by flow cytometry, and data are plotted relative to the corresponding GFP control, which was set to 100%. Depicted are mean values  standard
deviations of three independent experiments each performed in triplicate. Statistical significance was assessed by Student’s t test. ns, not significant; *, P 0.05;
**, P 0.01.
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prototypic of Nef.GFP-expressing cells). Silencing of PAK2
mostly resulted in Nef.GFP-expressing cells that spread well with
prominent F-actin rings (black bars, 66.3% of cells) and were un-
distinguishable from GFP-expressing control cells. In contrast,
reduced expression of EXOC components often resulted in Nef-
.GFP cells that failed to fully spread on the stimulatory surface but
displayed pronounced circumferential actin rings (32.4% and
29.8%of cells for siEXOC2 and siEXO4, respectively) (Fig. 5A and
FIG 4 EXOC does not affect Nef-mediated perturbations of host cell vesicular transport. (A) Cell surface CD4 levels. Jurkat T (CCR7) lymphocytes transiently
expressing GFP or SF2 Nef.GFP were stained with allophycocyanin (APC)-conjugated antibodies against CD4 and analyzed by flow cytometry. Gates of live
nontransfected and highly expressing cells are indicated. Red values are the mean fluorescence intensities of the CD4 signals in the respective gates. (B)
Quantification of relative CD4 cell surface levels as shown in panel A. Mean fluorescence intensity percentages of highly expressing and nontransfected cells
treated with shRNA or siRNA, as indicated, were calculated relative to the corresponding GFP control, which was set to 100%. Displayed are the mean values
the standard deviations from three independent experiments. (C andD) Cell surface CXCR4 levels. Primary fluorescence-activated cell sorting (FACS) plots (C)
and quantification (D) of cell surface CXCR4 levels as detected by APC-conjugated antibodies to CXCR4. (E and F) Cell surface MHC-I levels. Primary FACS
plots (E) and quantification (F) of cell surface MHC-I levels as detected by APC-conjugated antibodies to MHC-I. (G) Representative confocal micrographs of
Jurkat T (TAg) lymphocytes expressingGFPorNef.GFP in the context of shRNA-mediated depletion of PAK2, siRNA-mediated reduction of EXOC2or EXOC4,
or the respective control. Cells were plated onto coverslips, fixed, permeabilized, and stained for endogenous Lck, which accumulates in the TGN in the presence
of Nef. Asterisks designate GFP-positive cells. Values are themean percentages the standard deviations of cells with intracellular Lck accumulation from three
independent experiments. Scale bar, 10 m. For dual-color images, see Fig. S4C in the supplemental material.
Imle et al.
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FIG 5 EXOC facilitates inhibition of T cell receptor-induced actin rearrangements by Nef. (A) Representative confocal micrographs of Jurkat T lymphocytes
(Jurkat TAg) plated onto stimulatory coverslips for the induction of F-actin rings. Cells were treatedwith shRNAor siRNA, as indicated, prior to transfectionwith
GFP or SF2Nef.GFP expression plasmids. Fourminutes after being plated onto anti-CD3-coated coverslips, cells were fixed and permeabilized and F-actin was
(Continued)
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C). Quantification of the total cell spreading area confirmed that
PAK2 was critical for the inhibition of T cell spreading by Nef,
while EXOC had only moderate effects on this parameter
(Fig. 5D). Live cell imaging for extended times revealed that these
observed defects in cell spreading persisted over time (see Fig. S6
in the supplemental material), indicating that Nef not only delays
but blocks the spreading process in an EXOC-independent man-
ner. Cell spreading and actin remodeling upon TCR engagement
are prerequisites for proximal TCR signaling, which is character-
ized by a burst in tyrosine phosphorylation, a process that is effi-
ciently inhibited by Nef (19, 23, 26). Consistent with the findings
on F-actin ring formation, PAK2 and EXOCwere required for this
block in tyrosine phosphorylation by Nef (Fig. 5E and F). These
results imply that interactions with EXOC facilitate the inhibition
of TCR-induced actin remodeling and proximal signaling by Nef.
In order to dissect further the contribution of PAK2 and EXOC to
the Nef-mediated inhibition of TCR-triggered actin remodeling,
several shRNA-resistant mutant PAK2 proteins analyzed earlier
for the ability to reconstitute Nef-EXOC interaction in Jurkat
shPAK2 cells were analyzed for TCR-induced T cell spreading/
actin remodeling (see Fig. S7B and C in the supplemental mate-
rial). As expected, WT PAK2 reconstituted efficient inhibition of
T cell spreading and formation of circumferential F-actin rings by
Nef (19.8%  14.9% of cells). In contrast, kinase-dead K278R
mutant PAK2 failed to support this Nef activity (72.7% 11.9%
of cells), demonstrating that kinase activity, presumably via the
inactivation of cofilin, is essential for this process. Since K278R
mutant PAK2 still enables Nef to associate with EXOC, this result
also implies that Nef-EXOC interactions are not sufficient to ex-
plain the observed inhibition of TCR-induced actin ring forma-
tion by Nef. Consistently, H82L/H85L mutant PAK2, which, be-
cause of a lack of GTPase interaction, fails to trigger Nef-EXOC
association and does not enable kinase activation, also did not
support inhibition of TCR-induced actin remodeling by the viral
protein (65.0% 12.6% of cells). These results establish interac-
tion with EXOC as a novel and necessary step in the inhibition of
Nef-mediated inhibition of TCR-induced actin remodeling that
depends on prior Nef-PAK2 association and synergizes with the
effects exerted by the kinase activity of PAK2.
DISCUSSION
Inhibition of host cell actin remodeling constitutes one of the
conserved activities of lentiviral Nef proteins by which activation
status and motile behavior of infected cells in response to extra-
cellular stimuli are modulated to optimize virus replication in the
infected host. These activities were thought to rely exclusively on
the conserved association of Nef with the host cell kinase PAK2,
which, upon association with the viral protein, inactivates the
actin-severing factor cofilin by phosphorylation. Association of
HIV-1 SF2 Nef with PAK2 depends on an interaction site involv-
ing the critical residue F195, for which, until recently, PAK2 was
the only cellular ligand identified. The description of EXOC as an
additional interaction partner that depends on residues required
for PAK2 association raised questions regarding the specificity of
this interaction site, the potential mutual impact of PAK2 and
EXOCon each other, and the relevance of EXOC forNef function.
In our attempts to address these issues, we have confirmed that
HIV-1 Nef interacts with EXOC via its PAK2 interaction site, de-
tected this interaction in the context of HIV-1 infection, and es-
tablished the Nef-EXOC association as a feature that is conserved
in lentiviral evolution. Surprisingly, the presence of PAK2 was
strictly required for detection of the Nef-EXOC association. This
did not require PAK2 kinase activity but depended on residues
mediating its interaction with Rac1/Cdc42 GTPases. In turn,
EXOC had only amoderate effect on the ability of Nef to associate
with PAK2 activity, was dispensable for direct downstream effects
of Nef-PAK2 complexes on cofilin and chemokine-induced actin
dynamics, and did notmediate effects of Nef on host cell vesicular
transport. Functional relevance of EXOC was observed for the
Nef-mediated disruption of T cell responses to TCR engagement,
where EXOC was critical for the disruption of actin remodeling
and proximal TCR signaling.
Our results are most compatible with a model in which Nef
associates with PAK2 and EXOC in a sequential manner, where
the initial association with PAK2 facilitates Nef’s subsequent in-
teractionwith EXOC (see Fig. S8 in the supplementalmaterial). In
this scenario, transient Nef-PAK2 complexes are assembled in
which PAK2 is in its active phosphorylated state because of the
presence of the GTPases Rac1/Cdc42 and their guanine exchange
factor Vav in the complex. Once PAK2 is dissociated from the
complex, its substrate specificity is altered, leading to phosphory-
lation of cofilin and possibly additional substrates such as paxillin
(78) to impair host cell actin-remodeling events, including TCR-
induced cell spreading and actin polymerization. The GTPase
Cdc42, which interacts with PAK2 within Nef-PAK2 complexes,
also associates with EXOC (55, 56) and can recruit it for the for-
mation ofNef-EXOCcomplexes.On the basis of the abundance of
Nef-EXOC complexes that, in contrast to Nef-PAK2 complexes,
can easily be coimmunoprecipitated and detected by Western
blotting, associations of Nef with EXOC appear to be relatively
Figure Legend Continued
stained with phalloidin-TRITC. Asterisks indicate GFP-positive cells. Scale bar, 10 m. Further examples and dual-color images are provided in Fig. S5. (B)
Frequency of cells with circumferential F-actin rings shown in panel A. Displayed are mean values standard deviations of three independent experiments with
at least 100 cells counted per condition. (C) Stratification of cells shown in panel A into four different morphotypes based on F-actin ring formation and cell
spreading. The different morphotypes are depicted in the inset as follows: 1, fully spread cells with a circumferential F-actin ring (black bars); 2, incompletely
spread cells with a circumferential F-actin ring (dark gray bars); 3, fully spread cells lacking circumferential F-actin polymerization (light gray bars); 4, cells that
failed to spread and lacked a circumferential F-actin ring (white bars). The graph is representative of three independent experimentswith at least 100 cells counted
per condition. (D) Single-cell analysis of the cell areas of the cells shown in panel A. Single-cell areas were manually determined from micrographs by ImageJ.
Thirty to 40 cells with high GFP expression were randomly chosen and analyzed. Data points represent single-cell areas. Mean values standard deviations are
indicated, and the Mann-Whitney U test was used to determine significant differences from siCon GFP. (E and F) EXOC facilitates inhibition of proximal TCR
signaling by Nef. (E) Frequency of cells with pTyr microclusters shown in panel F. Displayed are mean values  standard deviations of three independent
experiments with at least 100 cells counted per condition. (F) Representative wide-field micrographs of Jurkat T (TAg) lymphocytes plated onto stimulatory
coverslips for the induction of F-actin rings and p-tyrosine microclusters. Cells were treated as described for panel A. Cells were stained with phalloidin-Alexa
Fluor 350 and rabbit anti-p-tyrosine antibodies and detected with Alexa Fluor 568-conjugated anti-rabbit antibody. Asterisks indicate GFP-positive cells. Scale
bar, 10 m. ns, not significant; *, P 0.05; **, P 0.01; ***, P 0.001.
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stable. This also suggests that PAK2 facilitates the formation of
Nef-EXOC complexes by virtue of its transient association with
Nef rather than acting as an integral component of Nef-EXOC
complexes.We thus propose that PAK2 acts as an adaptor protein
to facilitate the formation of Nef-EXOC complexes and, once dis-
sociated fromNef, as a direct Nef effector via its kinase activity. In
this scenario, PAK2 activity and EXOC are both necessary but not
sufficient for the inhibition of TCR-induced actin remodeling and
proximal signaling byNef. This is in contrast to the inhibition of T
lymphocyte actin remodeling and motility in response to chemo-
kines, which, as shown here, requires only the association of Nef
with PAK2 activity and not the subsequent formation of com-
plexes with EXOC. Why EXOC is specifically involved in actin
remodeling triggered byTCRbut not chemokine receptor engage-
ment remains an important topic of future studies. At this point,
we speculate that the involvement of EXOCmay be warranted for
the inhibition of processes that polarize toward the trigger (TCR
stimulatory surface or IS) while EXOC may be dispensable for
nonpolarized processes such as stimulation by a soluble chemo-
kine.
Another central aspect of this study was the characterization of
the role of EXOC in biological activities of Nef. Although only
moderate and transient reduction of EXOC expression was toler-
ated in our cell systems, these conditions significantly reduced the
efficiency of Nef-EXOC interactions. In contrast to the induction
of nanotubes (53), the Nef-regulated processes addressed here
were not impaired by reducing EXOC expression in the absence of
the viral protein. This indicated that, similar to PAK2, Nef hijacks
EXOC to retarget its biological activities, which allowed us to in-
vestigate the specific contribution of EXOC to Nef function. This
contribution, however,may be somewhat underestimated in these
experiments because of the moderate knockdown efficiencies. Si-
lencing of EXOC subunits did not impair the effects of Nef on the
subcellular localization of transmembrane (CD4, MHC-I,
CXCR4) and peripheral membrane (Lck) proteins. Relocalization
of host cell receptors by Nef is often mediated by blocking their
anterograde transport and requires the acidic stretch and the
proline-rich motif also involved in Nef-EXOC interactions. Con-
sidering that a primary function of EXOC consists of tethering
exocytic vesicles to the plasma membrane (79), it was somewhat
surprising that this complex was not involved in Nef activities
targeting anterograde vesicular membrane trafficking. However,
this result is consistent with the dispensability of the F195 residue
in SF2 Nef for these activities (16, 31, 40). This also implies that
Nef’s acidic stretch and proline-rich motif function indepen-
dently to interfere with host cell vesicular transport and actin dy-
namics. An involvement of EXOC in additional effects of Nef
such as triggering of exosome release still remains to be ana-
lyzed (80–82).
The identification of EXOC as a novel effector employed by
Nef to restrict TCR-induced actin dynamics and signaling is in
line with its ability to couple actin dynamics tomembrane remod-
eling (60) and suggests thatNef selectively targets this EXOC func-
tion. How Nef achieves this on the molecular level remains to be
elucidated. Given that EXOC per se was not essential in TCR-
induced actin remodeling, the association of Nef with EXOCmay
regulate the activity of the viral protein rather than affect general
EXOC functions. To decipher the underlying mechanism, it will
be necessary to identify the direct binding partner of Nef in Nef-
EXOC complexes, elucidate the stoichiometry of EXOCwhen it is
in a complex with Nef, and determine the precise subcellular lo-
calization of this interaction.
Considering the impact of Nef on HIV replication and disease
progression in AIDS patients, it would be important to add anti-
virals targeting Nef function to current treatment regimens. Al-
though some preliminary progress in this area has been reported
(83–85), therapeutic interference with Nef activity is complicated
by the lack of enzymatic activity and its mode of action as a mul-
tivalent protein interaction adaptor. An alternative strategymight
be to interfere with the activities of Nef’s interaction partners.
Because of their implication in many different types of cancer,
PAKs have become a subject of intense drug development efforts
(86, 87). The results of our study place PAK2 as the central down-
stream effector of Nef in the manipulation of host cell actin re-
modeling, suggesting that PAK2 inhibitors could be suitable for
interference with this Nef activity. However, we found that PAK2
facilitated Nef-EXOC interactions independently of its kinase ac-
tivity. Thus, development of compounds that can block PAK2
adaptor functionsmay be warranted to interfere with Nef activity,
a concept that may also be worthwhile to consider for the inhibi-
tion of PAKs in cancer. Irrespective of the mode of PAK2 action,
the PAK2 interaction surface in Nef represents an attractive target
for therapeutic interference, as it is essential for all downstream
effects of Nef-associated PAK2. The major challenge is to identify
a single compound that targets this overall conserved yet hetero-
geneously composed binding pocket across Nef proteins fromdif-
ferent HIV-1 subtypes and clades.
Together, our studies have unraveled a novel and surprising
role for EXOC in the inhibition of TCR-induced actin remodeling
by Nef, an activity implied in the optimization of virus spread and
immune evasion in vivo. This process is mediated by the stepwise
interaction of Nef with PAK2 and EXOC, which synergize in re-
programming the response of T lymphocytes to TCR engagement.
The binding pocket in Nef mediating association with PAK2 and
subsequently EXOC emerges as an attractive target for future drug
development.
MATERIALS AND METHODS
(See Text S1 in the supplemental material for additional Materials and
Methods.)
Cell culture and transfection.HEK293T cells were cultivated in Dul-
becco’s modified Eagle’s medium containing 10% fetal calf serum (FCS)
and 1% penicillin-streptomycin, which was further supplemented with
1 nonessential amino acids, 1 sodium pyruvate, 10 mM HEPES
(pH 7.4), and 45.76M -mercaptoethanol for Jurkat CCR7 cells. Jurkat
TAg cells (Jurkat cells expressing the simian virus 40 large T antigen) were
maintained in RPMI 1640 supplemented with 10% heat-inactivated FCS
and 1% penicillin-streptomycin (RPMI). For live microscopy, cells
were transferred to CO2-independent imaging medium (RPMIwith-
out phenol red, 20 mM HEPES, 2 mM sodium pyruvate). Puromycin
(4 g/ml; Sigma-Aldrich) was added for shRNA-transduced T cells to
select successfully transduced cells. Jurkat TAg and CCR7 cells were elec-
troporatedwith 30 to 50g of total plasmidDNAper 1 107 cells (250V,
950 and 850 F, respectively; Bio-Rad Gene Pulser). siRNA transfections
were conducted with 500 pmol per 1 107 cells, followed at 48 h by the
electroporation of GFP orNef.GFP expression constructs. Cells were sub-
jected to lysis or used for functional assays by immunofluorescence assay
or flow cytometry 24 h after DNA transfection.
Immunofluorescence. Responses to TCR engagement were moni-
tored by the formation of circumferential F-actin rings as previously de-
scribed (23). In brief, stimulatory coverslips were prepared by coating
with a 0.01% poly-L-lysine (PLL; Sigma-Aldrich) solution for 10 min at
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room temperature, followed by wet-chamber incubation for 3 h at 37°C
with 7 g/ml anti-CD3 (50 l per coverslip, clone HIT3a against CD3;
BD Biosciences) in phosphate-buffered saline (PBS). Stimulatory cover-
slips were subsequently washed in PBS and stored at 4°C in PBS until use.
For all other immunofluorescence analyses, coverslips were coated with
PLL for 30 min at 37°C. Transfected Jurkat TAg cells (3 105 or 5 105
per CD3-coated or PLL-coated coverslip, respectively) were used to seed
coverslips for 4 min to allow TCR-mediated actin ring formation or for
adherence to PLL. For induction of chemokine-induced ruffling, Jurkat
CCR7 cells on PLL were additionally allowed to respond to 200 ng/ml
SDF-1 (PeproTech) for 20 min. Cells were subsequently fixed in 3%
paraformaldehyde for 15 min, permeabilized for 2 min in 0.1% Triton
X100, and blocked for 30min in 1% FCS in PBS. An indirect immunoflu-
orescence assay was performed by incubating the cells with a mouse anti-
Lck antibody (clone 3A5; Santa Cruz; 1:50 overnight), a rabbit anti-p-
cofilin antibody (clone 77G2; Cell Signaling; 1:50 overnight, all steps in
Tris-buffered saline [TBS] instead of PBS), or a rabbit anti-p-tyrosine
antibody (clone PY350; Santa Cruz; 1:50 overnight in TBS) and a goat
anti-rabbit or goat anti-mouse secondary antibody coupled toAlexa Fluor
568 (1:2,000, 1 h room temperature; Invitrogen). For ruffle induction and
actin ring assays, F-actin was visualized with tetramethyl rhodamine iso-
thiocyanate (TRITC)-conjugated phalloidin (1:1,000, 1 h, room temper-
ature; Sigma). Samples were mounted on glass slides with Mowiol and
analyzed by epifluorescence (Olympus IX81 S1F-3, cellM software) and
confocal (spinning-disc PerkinElmer UltraView VoX, Volocity software)
microscopes. Life microscopy of actin ring formation was done with the
spinning-disc microscope at 37°C with a 40 objective and 10-m
Z-stacks with a 1-m interval every 10 s for 10 min. For quantification of
phenotype frequencies, at least 100 transfected cells were counted and
their phenotype was judged in comparison to that of untreated or un-
transfected neighboring cells. Single-cell analysis of cell spreading on
stimulatory coverslips was performed by manually circling 30 to 40 ran-
domly selected cells with high GFP fluorescence by using ImageJ.
Coimmunoprecipitation. Twenty-four hours posttransfection, cells
were counted and adjusted for equal GFP-positive cell numbers. Cells
were washed once with PBS and lysed in lysis buffer (1% Triton X-100,
150mMNaCl, 50mMTris HCl [pH 8.0], 1 mMNa3VO4, protease inhib-
itors at 1:1,000 [Sigma]) for 30 min on ice. Lysates were cleared by cen-
trifugation, mixed with 15 l of equilibrated GFP-Trap beads (Chro-
motek), and incubated with rotation for 2 h at 4°C. Beads were washed
three times with 500 l of wash buffer (150 mMNaCl, 1% Igepal CA-630
[equivalent toNP-40], 0.5% sodiumdeoxycholate, 0.1%SDS, 50mMTris
HCl [pH 8.0]) and once with 100 l of 20 mM Tris HCl (pH 7.5), and
protein was eluted in 30 l of hot 2 SDS sample buffer and boiled for
5 min. Samples of cleared input and eluates were analyzed by Western
blotting. To immunoprecipitate Nef from infected Jurkat CCR7 cells, the
above-mentionedprotocolwasmodified as follows. A total of 1 107 cells
from an infected culture were used per condition, and cell lysates were
incubated with sheep anti-Nef antiserum (1:200 ARP444, a gift from M.
Harris, Leeds University) for 45 min on ice. Meanwhile, protein A Sep-
harose beads (GE Healthcare) were blocked with a noninfected cell lysate
andwashed once in lysis buffer before being combinedwith the antibody-
loaded cell lysates. Quantification of coimmunoprecipitation efficiency
was based on the measurement of signal intensity with Quantity One
software (Bio-Rad). The percentages of coimmunoprecipitated EXOC
and immunoprecipitated GFP signals were calculated and correlated with
the percentages obtained for SF2 WT Nef, which were set to 100%.
IVKA. To assess Nef-associated PAK2 activity, standard IVKAs were
performed as previously described (35). Nef.GFP was immunoprecipi-
tated from transfected Jurkat TAg cells after lysis in KEB (137 mMNaCl,
50 mM Tris/HCl [pH 8], 2 mM EDTA, 0.5% Nonidet P-40, 1 mM
Na3VO4, protease inhibitors). Upon incubation with GFP-Trap beads,
samples were extensively washed with KEB and resuspended in 50 l of
KAB (50 mMHEPES [pH 8], 150 mMNaCl, 5 mM EDTA, 0.02% Triton
X-100, 10 mMMgCl2) containing 10Ci of [-32P]ATP (Hartmann An-
alytic) per reaction. After 10 min of incubation at room temperature,
samples were repeatedly washed in KEB, mixed with 2 SDS sample
buffer, and boiled. Bound proteins were separated by SDS-PAGE and
subjected to autoradiography. For pharmacological inhibitor experi-
ments, GFP- or Nef.GFP-transfected Jurkat T lymphocytes were incu-
bated for 1 h with 10 M PAK2 kinase inhibitor IPA3 (catalog no. 3622;
Tocris) or its inactive pharmacological control PIR3.5 (catalog no. 4212;
Tocris) and then subjected to IVKA.
Statistical analysis. Statistical analysis of data sets was carried outwith
Microsoft Excel and GraphPad Prism. The statistical significance of para-
metrically and not normally distributed data sets was analyzed with the
Student t test and the Mann-Whitney U test, respectively.
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